Latest seminars and webinars organised by FinPharmaNet.
Webinars take place every Tuesdays via Zoom at 3 pm or 4 pm (Helsinki time; EST). Max time 45 min + 15 min discussion.
Webinares hosted by Prof. Mikko Airavaara, Faculty of Pharmacy, University of Helsinki.
Past seminars
- Dr. Rana Rais ( Johns Hopkins Medicine, Baltimore, MD, USA)
- 1.2.2022 at 3 pm, Glutamine Antagonist Prodrug Discovery: “A story of BENCH 2 BEDSIDE”
- Professor Rajesh K. Maheshwari S.G.S.I.T.S., India
- 8.3.2022, 3 pm; Novel applications of solubilizing properties of safe and economic solids in various fields of pharmacy giving green methods minimizing the use of harmful organic solvents"
- Dr. Eric M Prager (Associate Director, Translational Research & Development, Cohen Veterans Bioscience)
- 15.3.2022, 4 pm; A Framework to Optimize Research Rigor and Reproducibility
- Prof. Elisabet Jerlhag (University of Gothenburg, Sweden)
- 29.3.2022, 3 pm; Gut brain axis in alcohol use disorder
- Dr. Matthias Herth (University of Copenhagen, Denmark)
- 5.4.2022, 3pm; The Tetrazine Ligation - A bioorthogonal reaction for Organic Chemistry in humans
- Prof. Risto Kaaja (University of Turku, Finland)
- 19.4.2022; 3 pm.; Pregnancy - window to woman's health offering possibility to primary prevention.
- Dr. Anna Erlandsson (Department of Public Health and Caring Sciences, Uppsala University, Sweden)
- 26.4.2022, 3 pm.; Astrocytes - a possible treatment target to halt Alzheimer’s disease progression
- Dr. Kert Mätlik (Rockefeller University, New York, USA)
- 3.5.2022, 3 pm; Cell type-specific vulnerability of striatal neurons in Huntington's disease
- Prof. Poul Henning Jensen, M.D., Dr. Med. Sci. Aarhus University, Dept. of Biomedicine & DANDRITE, Danish Research Institute of Translational Neuroscience
- 10.5.2022, 3 pm; New non-inclusion a-syn aggregate neuropathology – how to detect it, does it matter and can we counteract it?
- Dr. Jarkko Rautio, University of Eastern Finland
- 26.10.2021; Prodrug strategies to overcome problems in drug therapy
- Dr. Susanne Bäck, Charles River, Kuopio
- 2.11.2021; Animal models in drug discovery and development - a CRO perspective
- Dr. Timo Myöhänen, University of Eastern Finland
- 15.11.2021, NOTE ON MONDAY!, From inhibitors to ligands – PREP modulation in the models of neurodegenerative disease
- Dr. Heidi Kidron, University of Helsinki
- 23.11.2021, Cause and effect of variation in drug transporter activity
- Dr. Robert Luxenhofer, University of Helsinki
- 30.11.2021; Ultra-high loaded nanoformulations of poorly soluble drugs and drug candidates: Structure-property relationships, safety and efficacy
- Dr. Ville Paavilainen, University of Helsinki
- Dr. Matti Poutanen, University of Turku
- 14.12.2021; HSD17B-enzymes: Potential drug targets for modulating of steroid and lipid synthesis
- Prof. Vânia M. Moreira (Universidade de Coimbra, Portugal)
- 12.01.2021: Explorations into the medicinal chemistry of the abietanes: a tale of innovative antimicrobial compounds and materials
- Prof. João F. Pinto (Universidade de Lisboa, Portugal)
- 19.01.2021: Additive Manufacture of Medicines – 3D Printing, the 4th industrial revolution in manufacture
- Prof. Michael Courtney (University of Turku, Finland)
- 02.02.2021: Identifying and monitoring druggable pathways in neurons
- Prof. Bruno Sarmento (i3S - University of Porto, Portugal)
- 09.02.2021: Cell-based in vitro models for the validation of no-systemic drug delivery
- Dr. Bert van Veen (Orion Pharma - Biopharmaceutics, Finland)
- 16.02.2021: Evolution of small chemical entities towards amorphous solid dispersions
- Prof. Tomi Rantamäki (University of Helsinki, Finland)
- 02.03.2021: Rapid-acting antidepressants and sleep
- Prof. Jyrki Heinämäki (University of Tartu, Estonia)
- 09.03.2021: Needleless electrospinning of nanofibers
- Dr Christine-Maria Horejs (Chief Editor, Nature Reviews Materials)
- 30.03.2021: Scientific writing and publishing – insights from an editor
- Prof. Hongbo Zhang (Åbo Akademi University, Finland)
- 06.04.2021: Functional Materials in Biomedical Engineering
- Dr. Vimalkumar Balasubramanian (Bayer Oy, Finland)
- 20.04.2021: Nanomedicine in Pharma perspective: past, present and future
- Prof. Luca Casettari (University of Urbino, Italy)
- 11.05.2021: 3DP: from nano to devices
- Prof. Tambet Teesalu (University of Tartu, Estonia)
- 18.05.2021: Homing peptides and precision nanomedicine
- Prof. Christel Bergström (Uppsala University, Sweden)
- 29.9.2020 The virtual intestine – a simulation environment to understand advanced drug delivery
- Dr. Mia Bengtström (Pharma Industry Finland)
- 7.10.2020 Pharma Industry Finland
- Prof. Natasa Skalko-Basnet (University of Tromsø, Norway)
- 13.10.2020 Treating genital infections: is current treatment the best we can do?
- Dr. Ruth Schmid (SINTEF AS, Norway)
- 21.10.2020 Ultrasound-enhanced drug delivery using nanoparticle-stabilized microbubbles
- Dr. Sara Cordeiro (Queen's University Belfast, Northern Ireland)
- 3.11.2020 Microarray patches for transdermal drug delivery and diagnostic approaches